The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
D000339:Affect; D000661:Amphetamine / Q000378:metabolism / Q000627:therapeutic use; D001143:Arousal; D001289:Attention Deficit Disorder with Hyperactivity / Q000209:etiology / Q000235:genetics; D001341:Autonomic Nervous System / Q000503:physiopathology; D001921:Brain / Q000378:metabolism; D001925:Brain Damage, Chronic / Q000209:etiology*; D002395:Catecholamines / Q000378:metabolism*; D002648:Child; D002653:Child Behavior Disorders / Q000209:etiology; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006948:Hyperkinesis / Q000209:etiology; D008661:Metabolism, Inborn Errors / Q000150:complications*; D008954:Models, Biological; D008960:Models, Psychological; D018377:Neurotransmitter Agents / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D011379:Prognosis; D012054:Reinforcement, Psychology; D012701:Serotonin / Q000378:metabolism*
D002395:Catecholamines; D018377:Neurotransmitter Agents; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine